Ignite Creation Date:
2025-12-24 @ 5:54 PM
Ignite Modification Date:
2026-03-01 @ 5:00 PM
Study NCT ID:
NCT02124668
Status:
COMPLETED
Last Update Posted:
2024-11-21
First Post:
2014-04-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Sponsor:
Astellas Pharma Europe B.V.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09-23
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-25
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-25
First Submit QC Date:
None
Study First Post Date:
2014-04-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-19
Last Update Post Date:
2024-11-21
Last Update Post Date Type:
ACTUAL